Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2003
05/28/2003EP1313726A1 Quinoline derivatives having vegf inhibiting activity
05/28/2003EP1313725A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
05/28/2003EP1313711A2 Indazole derivatives as jnk inhibitors
05/28/2003EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors
05/28/2003EP1313705A1 Gem-substituted alpha v beta 3 integrin antagonists
05/28/2003EP1313700A1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
05/28/2003EP1313695A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
05/28/2003EP1313514A2 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
05/28/2003EP1313513A2 Identification, diagnosis, and treatment of breast cancer
05/28/2003EP1313512A1 Vascular endothelial growth factor 2
05/28/2003EP1313509A2 Treatment of tumors with acetylenes distributed with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents
05/28/2003EP1313508A2 Combination containing an antifolate and methylmalonic acid lowering agent
05/28/2003EP1313505A1 Hla binding peptides and their uses
05/28/2003EP1313504A2 Methods and compositions for inhibiting angiogenesis
05/28/2003EP1313499A1 Method for treating the central nervous system by administration of igf structural analogs
05/28/2003EP1313498A2 Phospholipase d effectors for therapy and screening
05/28/2003EP1313491A1 Bioactive fraction of eurycoma longifolia
05/28/2003EP1313480A2 Use of an arylaldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer
05/28/2003EP1313469A1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections
05/28/2003EP1313468A2 Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors
05/28/2003EP1313463A1 Fatty acid analogues for the treatment of cancer
05/28/2003EP1313462A1 Use of asiatic acid or asiaticoside for treatment of cancer
05/28/2003EP1313461A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
05/28/2003EP1313450A1 A method of treating a systemic disease
05/28/2003EP1313377A2 Treatment of helicobacter with isothiocyanates
05/28/2003EP1278412A4 Polymer conjugates of ara-c and ara-c derivatives
05/28/2003EP1206462B1 Heterocyclic compounds inhibiting angiogenesis
05/28/2003EP1165115B1 Modulation of vascular permeability by mean of tie2 receptor activators
05/28/2003EP1165108B1 Use of a serenoa repens extract for the production of a medicament to treat prostate cancer
05/28/2003EP1161428B1 Pyrimidine compounds
05/28/2003EP1100777B1 Sulfurated distamycin derivatives, process for preparing them, and their use as antitumor agents
05/28/2003EP1056358B1 Use of d-tagatose as a prebiotic food component
05/28/2003EP1011682B1 Hormonal contraceptive
05/28/2003EP0988048A4 Ligand/lytic peptide compositions and methods of use
05/28/2003EP0981358B1 Dolastatin-15 derivatives in combination with taxanes
05/28/2003EP0973763B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
05/28/2003EP0956027B1 Semi-synthetic sulphaminoheparosansulphates having high anti-metastatic activity and reduced haemorrhagic risk
05/28/2003EP0941253B1 New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
05/28/2003EP0888352B1 Fused imidazole derivatives as multidrug resistance modulators
05/28/2003EP0874814B1 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols
05/28/2003EP0850222B1 Piperazine derivatives and process for the preparation thereof
05/28/2003EP0830604B1 Uses of apoptin
05/28/2003EP0814792B1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
05/28/2003EP0788509B1 Therapeutic peptide derivatives
05/28/2003EP0788360B1 Boronic ester and acid compounds, synthesis and uses
05/28/2003CN1420933A Method of inducing angiogenesis by micro-organs
05/28/2003CN1420926A Anti-angiogenic proteins and fragments and methods of use thereof
05/28/2003CN1420889A Pharmaceutically active isoindoline derivs.
05/28/2003CN1420888A Substd. pyrazoloÒÇö4,3-eÒÇòdiazepines, pharmaceu-tical compositions contg. them, use as medicinal products and processes for preparing them
05/28/2003CN1420887A 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors
05/28/2003CN1420884A 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders
05/28/2003CN1420882A Substd. oxoazaheterocyclyl compounds
05/28/2003CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha
05/28/2003CN1420880A Substd. N-Benzyl-indol-3-yl glyoxylic acid derivs. having anti-tumoral effect
05/28/2003CN1420879A Substd. pyridines and pyridazines with angiogenesis inhibiting activity
05/28/2003CN1420878A Compound with growth hormone releasing properties
05/28/2003CN1420872A Caspase inhibitors and use thereof
05/28/2003CN1420790A Transporters and drug delivery system by using same
05/28/2003CN1420789A Compound for targeting
05/28/2003CN1420787A Magnetic targeted carrier composed of iron and porous materials for targeted delivery of biologically active agents
05/28/2003CN1420785A Method of treating cancer with anti-neurotrophin agents
05/28/2003CN1420784A Vaccine for treatment of tubercolosis and other intracellular infections diseases and preparing process thereof
05/28/2003CN1420783A Compositions and methods for tumor-targeted delivery of effector molecules
05/28/2003CN1420782A Immune enhancing compositions
05/28/2003CN1420779A Nucleoside analogs with carboxamidine-modified bicyclic base
05/28/2003CN1420776A Inhibition of cyclooxygenase-2 activity
05/28/2003CN1420768A Combination product comprising non-steroidal antiandrogen and EGFR tyrosine kinase inhibitor
05/28/2003CN1420765A Method for chemoprevention of prostate cancer
05/28/2003CN1420762A Devices for delivery of drugs having antiprogestinic properties
05/28/2003CN1420723A Compositions and methods for L-nucleosides, and their analogs
05/28/2003CN1420169A Multifunctional anticancer recombinant adenovirus and use thereof for treating and preventing tumor
05/28/2003CN1420129A Humanized anti-CD 20 monoclonal antibody
05/28/2003CN1420128A Humanized anti-HER 2 monoclonal antibody, its preparation method and pharmaceutical composition thereof
05/28/2003CN1420111A Naphthalene alizarin derivatives, preparing method and use thereof
05/28/2003CN1419935A Specific medicine for treatiug AIDs, cancer and hepatitis, and health product for recovery
05/28/2003CN1419931A Radix zanthoxyli powder injection and preparing method thereof
05/28/2003CN1419924A Antineoplastic Chinese patent drug
05/28/2003CN1109687C Macrolides with antitumor activity, method for preparing same and use thereof
05/28/2003CN1109686C Acronycine compounds and pharmaceutical compositions contg. them
05/28/2003CN1109685C Substd. benzocycloheptapyridine derivs. useful for inhibition of farnesyl protein transferase
05/28/2003CN1109551C Medicine for treating cancer and process for preparing same
05/27/2003US6570002 Inhibitor of programmed cell death
05/27/2003US6569996 Antibody that specifically binds to the cadherin-5 cell adhesion recognition sequence
05/27/2003US6569995 Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells
05/27/2003US6569902 Inhibiting initiation or development of cancer by administering an effective dose of a nitrone free radical trapping agent to a subject
05/27/2003US6569896 Useful for oral testosterone replacement therapy, male contraception, maintaining sexual desire in women, treating prostate cancer and imaging prostate cancer
05/27/2003US6569893 Amino acid derivatives of triptolide compounds as immune modulators and anticancer agents
05/27/2003US6569890 Cyclic AMP-specific phosphodiesterase inhibitors
05/27/2003US6569885 Cyclic AMP-specific phosphodiesterase inhibitors
05/27/2003US6569878 Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors
05/27/2003US6569877 Benzimidazolyl phenyl anticancer agents
05/27/2003US6569872 Use of neurokinin receptor antagonists to treat androgen-dependent diseases
05/27/2003US6569870 Fluorinated quinolones as antimitotic and antitumor agents
05/27/2003US6569858 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo[3,4-c]carbazole and 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]carbazoles
05/27/2003US6569855 Particularly zinc metalloprotease activity for treatment of variety of maladies involving inflammation and/or tissue integrity
05/27/2003US6569853 Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
05/27/2003US6569847 Inhibitors of cathepsins for treating muscular dystrophy, osteoporosis, rheumatoid arthritis, neuronal or cardiac ischaemia, allergy, or Chagas disease
05/27/2003US6569846 Photodynamic therapy and diagnosis and in vitro photodynamic killing of viruses and microorganisms
05/27/2003US6569844 Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives
05/27/2003US6569842 Method of preparing and use of prodrugs of betulinic acid derivatives
1 ... 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 ... 2211